Douglas Mann, MD: Challenging The Prevailing Dogma

Video

Experts at the European Society of Cardiology Congress 2016 (ESC) expressed varied opinions on the DANISH trial. Researchers presented that implantable cardioverter-defibrillators (ICDs) do not work for all heart patients.

Douglas Mann, MD expressed his opinion regarding the results of the DANISH trial that were presented today at the European Society of Cardiology Congress 2016 (ESC). "Technically the trial is neutral or people want to say negative, but from a clinical stand point, the device does work - just not in everybody," Mann remarked. According to Mann, in patients older than 70 years, physicians might be more conservative about recommending ICDs; there was also a 5% rate of complications in placing ICDs, which is relatively high in this age group.

Related Videos
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
© 2024 MJH Life Sciences

All rights reserved.